CeMo₈O₁₄, a Third Crystalline Form of the RMo₈O₁₄ Series (R = La, Ce, Pr, Nd, Sm)

The structure of CeMo₈O₁₄ contains an equal mixture of cis-edge-sharing and trans bicapped octahedral Mo₈ clusters arranged in layers. The oxygen framework derives from close-packed layers with the sequence ABAC. The Ce³⁺ ions are surrounded by 12 O atoms forming a distorted cuboctahedron.

Structure Refinement of Y₂Ru₂O₇ by Neutron Powder Diffraction

The structure of the pyrochlore Y₂Ru₂O₇ was determined by Rietveld analysis of time-of-flight neutron powder diffraction data. Each Ru atom has a nearly regular octahedral coordination environment whereas each Y atom has distorted eightfold coordination geometry.

Structure Refinement of Orthorhombic MnAl₃

Structure refinements of Mn₃Al₁₀ were performed in the space groups Pnma and Pn2₁a. All atom sites in Pn2₁a were within 3σ from those in Pnma, except for three Al positions, which were within 6σ. The space group Pnma was found to be correct.

Silicatoniobate de Potassium, K₃Nb₃O₆Si₂O₇

The structure of K₃Nb₃O₆Si₂O₇ is built up from Si₂O₇ ditetrahedra and groups of three corner-linked NbO₆ octahedra. The framework is isotypic with that of Ba₃Nb₆O₁₂(Si₂O₇)₂, but the filling of the tunnels with K⁺ ions rather than Ba²⁺ ions determines the space group to be P\=62c.

CaV₂O(PO₄)₂, Isotypic with the Cd Phase

The structure of this new vanadium(III) monophosphate contains [VO₄]_∞ rutile chains and VPO₈ units, each formed from a VO₆ octahedron sharing an edge with a PO₄ tetrahedron.

Hydroxylammonium Sulfate

The structure of (NH₃OH)₂SO₄ consists of sulfate and hydroxylammonium ions, which are connected by O-H⋯O and N-H⋯O hydrogen bonds. All O atoms of the sulfate groups are involved in two hydrogen bonds.

An Inclusion Complex of Uranyl in a Di­azacrown: (Di­aza-18-crown-6)²⁺.2CF₃SO₃⁻ and [UO₂(di­aza-18-crown-6)]⁺.CF₃SO₃⁻

Two Lasalocid Sodium Salts

μ-[N,N-Bis(2-pyridylmethyl-1κN)-N',N'-bis­(2-pyridylmethyl-2κN)-1,3-di­aminopropan-2-olato]-1κN,2κN',1:2κ²O-bis­(dioxovanadium)(1+) Iodide Dihydrate, [(VO₂)₂(TPHPN)]I.2H₂O

Penta­carbonyl-1κC,2κ⁴C-bis­[1,1(η⁵)-cyclo­pentadienyl](di­methylphenylphosphine-2κP)-μ-di­methylphosphanido-niobiumtungsten

A Mononuclear Manganese(III) Schiff Base Complex, [Mn(C₁₄H₁₀N₂O₂)(C₈H₇O₃)(CH₄O)]

Aqua­chloro[bis­(5-chlorosalicyl­idene)ethylenediaminato]manganese(III)

cis,trans-(2,2'-Bi­pyridine-N,N')di­bromobis(4-methylpyridine-N)tungsten(II)

Tris(2,2'-bi­pyridine)manganese(II) Perchlorate Hemihydrate

Bis(acetato)amminedi­chloro(cyclo­hexylamine)platinum(IV), an Orally Active Anticancer Drug

Tetra­chloro­penta­kis­(di­methyl sulfoxide)diruthenium(II)

(2,3,7,8,12,13,17,18-Octa­ethylporphinato)perchloratomanganese(III)

[(R)-1,2-Di­ethoxycarbonylethyl]bis­(di­methylglyoximato)(methyldi­phenylphosphine)cobalt(III)

A Redetermination of the Crystal Structure of Bis(cyclo­pentadienyldi­carbonylruthenium)

Tri­chlorotin(II)–(meso-Tetra­phenylporphyrinato)rhodium(III), a Porphyrin Derivative with an Rh—Sn Bond

Bis(3-methylpyridine)bis­[4,4,4-tri­fluoro-1-(2-thienyl)-1,3-butanedionato]nickel(II)

Sodium Bis(dipicolinato)ferrate(III) Dihydrate

{exo-2,7,11-μ₃-[(μ-H)₂Cu(PPh₃)]-2-(PPh₃)-closo-2,1-CuTeB₁₀H₈}.CH₂Cl₂

Two Ternary Ni^II Complexes: Bisglycinato(1,10-phenanthroline)nickel(II) Trihydrate and Bisglycinato(2,2'-bi­pyridine)nickel(II) Trihydrate

[3,9-Di­methyl-4,8-di­aza-3,8-undecadiene-2,10-dione dioximato(1–)](thio­cyanato)copper(II) and [3,6,6,9-Tetra­methyl-4,8-di­aza-3,8-undecadiene-2,10-dione dioximato(1–)](iso­thio­cyanato)copper(II)

Di­iodo­tetra(pyridine-N)copper(II)zinc(II) Di­pyridine

Aqua(glycinato)(3,4,7,8-tetra­methyl-1,10-phenanthroline)copper(II) Nitrate

Bis(tetra-n-butylammonium) Bis(μ-1,1-di­cyanoethene-2,2-di­selenolato)dithallate(I) Acetone Solvate, [(C₄H₉)₄N]₂[Tl₂{Se₂C=C(CN)₂}₂].2(CH₃)₂CO

Mercury(II) Chloride Adduct of a Betaine Derivative: Bis[(di­methyl)(2-di­methylamino­ethyl)ammonio­acetato]tetra­kis­[di­chloromercury(II)]

cis-Di­pyridine Complex of Bis(ω-nitroacetophenonato)zinc(II)

Di­chloro[(Z)-2-chloro-2-phenylvinyl](4-methoxyphenyl)tellurium(IV)

Bis[bis­(3,5-di­methyl-1-pyrazolyl)phosphinato]copper(II), [Cu{O₂P(N₂C₃HMe₂)₂}₂]

Dipyridinio­methane trans-Di­chloro­tetra­fluoroosmate(IV) Hydrate, trans-[(C₅H₅N)₂CH₂][OsF₄Cl₂].H₂O

Three Polymorphs of Potassium 4-Sulfonato­benzoic Acid

An Unexpected By-Product in the Friedel–Crafts Acrylation of Ferrocene

The 7,7,8,8-Tetra­cyanoquinodi­methane Salt of (C-meso-5,5,7,12,12,14-Hexa­methyl-1,4,8,11-tetra­aza­cyclo­tetra­decane)nickel(II), [Ni(C-meso-Me₆[14]aneN₄)](TCNQ)₂

trans-Hydroxotris(iso­thio­cyanato)bis­(tri­phenylphosphine)rhenium(IV) Methanol Solvate

Chlorure de cis-Chloro(diméthyl sulfoxyde)(metformine)platine(II)

Schiff Bases and Their Complexes with Metal Ions. I. 2-Hy­droxy-N-n-propyl-1-naphthaldimine (1) and Bis(2-hy­droxy-κO-N-n-propyl-1-naphthaldiminato-κN)nickel(II) (2)

A New Schiff Base Complex: {N-[3-(2-Amino­ethylamino)propyl]salicylideneaminato-O,N,N',N''}bromozinc(II)

Cholesteryl 4-Vinylbenzoate

rac-1,1,4-Tri­methyl-5-tri­methylsilyl-1,3,3a,4,6,7,8,9-octa­hydro-1-sila­naphtho[1,2-c]furan at 153 K

5-Do­decyl-2-(1-hydroxyethyl)benzimidazolium Chloride

Octaanisyl Cavitands and a Related Caviplex

Syn and Anti Isomers of [2.2]Para­cyclonaphthane

Triterpenoide. VII. Über die Struktur von neuen 2-oxa- und 1,2-seco-Derivaten des Olenanolsäure­methylesters

Product of an S_N2' Ring-Opening Reaction, (1R*,2R*,3R*,4R*,7R*)-2,4,7-Tri­methylcyclohept-5-ene-1,3-diol

Fortesyl 2-Phenylpropionate. An Example of a Novel Hydrocarbon Skeleton Containing Three Fused Five-Membered Rings

N,N-Di­methyl-2-[7-(methylamino­sulfonylmethyl)-1-naphthyl]ethylamine, the Naphthalenic Bioisostere of Sumatriptan

Bis(2-imidazolyl)amino­methane Tris(hydrochloride)

Methyl N-(4-Chloro­phenylamino­thio­carbonyl)benzimidate

o-Anisidinium Di­hydrogenmonophosphate

m-Anisidinium Di­hydrogenmonophosphate

N,N-Di­ethyl-4-(methylsulfonyl)-2-nitroaniline

KR-25003, a Potent Analgesic Capsaicinoid

Stereochemistry of Asymmetric β-Lactam Formation Involving Achiral Glyoxylamide Derivatives

p-Anisidinium Di­hydrogénophosphate

(R,S)-1-Phenylethylammonium (R,S)-Mandelate

8-Acid Derivative of the Antitumour Agent Mitozolomide

Heptahydrated Monosodium Salt of 6-Amino-5-(2-carboxyphenyl)azouracil

A 1,2-Di­hydrodipyrido[1,2-b:3',2'-d]pyrazol-2-one

3-Methyl-4H-pyrido[3,2-e][1,2,4]thiadiazine 1,1-Dioxide

3-Methyl-4H-pyrido[4,3-e][1,2,4]thiadiazine 1,1-Dioxide Monohydrate

trans-2-[(Di­spiro[2.0.2.1]hept-7-yl)carbonyl]-3-methyl-β-propiolactone

1-Benzyl-5-methoxycarbonylmethylthio-4-nitro­imidazole

endo-3,3-Di­phenyltri­cyclo[3.2.1.0^2,4]oct-6-ene

Bromure de Benzododécinium Monohydraté

Coumarin 314

3-Hydroxyimino-5α,13α,14β,17α-lanosta-8,24-dien-20-oic Acid

Ethyl 3-(4-Chlorophényl)-3a-méthyl-5-phényl-3,3a,4,11-tétra­hydro-3H-[1,2,4]triazolo[4,3-a][1,5]benzodiazépine-1-carboxylate, C₂₆H₂₃ClN₄O₂

Azoles. 38. Struktur der Molekularverbindung von 3,5-Di­nitroindazol, 5-Nitro-3-piperazinoindazol und Methanol

(±)-3-Methyl-1,1-di­phenyl-2-butyl 3-Acetamidocrotonate and its Hydrogenation Product

Un sel de Maprotiline (Ludiomil), Médicament Psychotrope, C₂₀H₂₄N⁺.C₂₁H₂₂NO₂⁻.0,5H₂O

2-Acrylamido-2-hydroxymethylpropan-1,3-diol

N-Phenylsulfonyl-N-o-chloro­phenylmethacrylamide, C₁₆H₁₄ClNO₃S

6-Chloro-1-ethyl-1,4-di­hydro-4-oxo-7-(4-methyl-1-piperazinyl)-1,8-naphthyridine-3-carboxylic Acid, C₁₆H₁₉ClN₄O₃

Methyl (2S,6S:2R,6R)-6-(2-Cyano­ethyl)-4,6-di­methyl-2-morpholine­acetate

Lactonization Products of 2-[(2,6-Di­methoxyphenyl)ethynyl]-3-methoxybenzoic Acid

endo-1,10,11,12,13,13-Hexa­chlorotri­cyclo[8.2.1.0^2,9]trideca-11-ene

3-(4-Methylphenyl)-1-(3-thienyl)-2-propen-1-one

N-[2-(3-Methoxyphen­oxy)propyl]-m-tolylacetamidinium p-Toluene­sulfonate Monohydrate (Xylamidine)

tert-Butyl 2-[(Hy­droxy)(5-hy­droxy-1,3-benzodioxol-6-yl)methyl]pyrrolidine-1-carboxylate

An Intramolecular Diels–Alder Adduct in the Hy­droxy-β-ionone Series

Tripotassium Phosphoglycolate Dihydrate and Tris(cyclo­hexylammonium) Phosphoglycolate Trihydrate

Potassium D-3-Phosphoglycerate and Cyclo­hexylammonium D-3-Phosphoglycerate Hydrate

Oxidation of 5,6-Di­amino-1,3-di­methyluracil by Metal Ions: Structure of 1,3,6,8-Tetra­methyl-2,4,7,9(1H,3H,6H,8H)-pyrimido[4,5-g]pteridinetetrone

α,α-allo-Trehalose Trihydrate

α,α-galacto-Trehalose

4,4'-Di­meth­oxy-2,2'-[di­thiobis(o-phenylene­nitrilo­methyl­idyne)]diphenol

Benzyl 2-Acetamido-4-azido-3-O-benzoyl-6-O-(tert-butyldi­phenylsilyl)-2,4-di­deoxy-β-D-gluco­pyranoside

Conformational Studies of trans-1,4-Substituted Cyclo­hexanes. I. trans-1,4-Cyclo­hexanedicarbo­nitrile

Conformational Studies of trans-1,4-Substituted Cyclo­hexanes. II. trans-1,4-Di­bromo-1,4-cyclo­hexanedicarbo­nitrile, C₈H₈Br₂N₂

5-(Iso­propylamino)-8-methyl-2-quinolone

Structure of tris­(pyridine)mercury(II) bis­(tri­fluoro­acetate). Erratum

Correction to Acta Cryst. (1978), B34, 3758-3760.